Abstract:ABSTRACT. We report the finding of mitochondrial ATPsynthase deficiency in a child with persistent 3-methylglutaconic aciduria. The child presented in the neonatal period with severe lactic acidosis, which was controlled by Na-H C 0 3 and glucose infusions. During the 1st y of life, there were several episodes of lactic acidosis precipitated by infections or prolonged intervals between meals. The excretion of lactate in urine was variable, but there was a persistent high excretion of 3-methylglutaconic acid. T… Show more
“…The high ATPase threshold is likely to rescue the energy supply to some extent; however, it might differ in cells and tissues with different genetic background. From the three earlier reported patients with decreased ATPase and absence of mitochondrial mutations, two died within the first days of life (13,14) and one survived for several years (12). Similar to the previous two reported patients who lacked mutations of the mitochondrial genes ATP6 and ATP8 (12, 13), a clear reduction of the hydrolytic activity of mitochondrial ATPase (oligomycin sensitive) was found in investigated tissues.…”
The F o F 1 -ATPase, a multisubunit protein complex of the inner mitochondrial membrane, produces most of the ATP in mammalian cells. Mitochondrial diseases as a result of a dysfunction of ATPase can be caused by mutations in mitochondrial DNA-encoded ATPase subunit a or rarely by an ATPase defect of nuclear origin. Here we present a detailed functional and immunochemical analysis of a new case of selective and generalized ATPase deficiency found in an Austrian patient. The defect manifested with developmental delay, muscle hypotonia, failure to thrive, ptosis, and varying lactic acidemia (up to 12 mmol/L) beginning from the neonatal period. A low-degree dilated cardiomyopathy of the left ventricle developed between the age of 1 and 2 y. A Ͼ90% decrease in oligomycin-sensitive ATPase activity and an 86% decrease in the content of the ATPase complex was found in muscle mitochondria. It was associated with a significant decrease of ADP-stimulated respiration of succinate (1.5-fold) and respiratory control with ADP (1.7-fold) in permeabilized muscle fibers, and with a slight decrease of the respiratory chain complex I and compensatory increase in the content of complexes III and IV. The same ATPase deficiency without an increase in respiratory chain complexes was found in fibroblasts, suggesting a generalized defect with tissue-specific manifestation. Absence of any mutations in mitochondrial ATP6 and ATP8 genes indicates a nuclear origin of the defect. Mitochondrial disorders caused by impairment of mitochondrial oxidative phosphorylation (OXPHOS) affect predominantly tissues with high-energy demands: muscle, brain, and heart. Subunits of OXPHOS complexes are encoded in two separate genomes: nuclear and mitochondrial. A pathogenic mutation in both genomes can cause an OX-PHOS defect. Defects in complex V-mitochondrial F o F 1 -ATPase are less frequent than the defects of the respiratory chain complexes, but they are mostly very severe and can be caused by mitochondrial DNA (mtDNA) mutations or by mutations in nuclear genes.Mitochondrial ATPase is a multisubunit complex composed of 16 different subunits (1). Six of these compose the globular F 1 part, which is responsible for enzymatic catalysis of ATP synthesis or hydrolysis. Ten remaining subunits form the membrane-spanning F o part, which performs H ϩ translocation across the inner mitochondrial membrane. Four subunits of F o form stalks that connect F 1 and F o parts. Only two subunits from F o part are encoded by mitochondrial genome: subunits a and A6L (subunits 6 and 8) (2). All of the other 14 subunits of the ATPase are encoded by the nuclear genes.Specific defects in mitochondrial ATPase are caused mainly by mtDNA mutations that affect subunit a; no mutations in subunit A6L have been described so far. The most frequent mutation in subunit a is T8993G mutation (3-7) or T8993C mutation (8)
“…The high ATPase threshold is likely to rescue the energy supply to some extent; however, it might differ in cells and tissues with different genetic background. From the three earlier reported patients with decreased ATPase and absence of mitochondrial mutations, two died within the first days of life (13,14) and one survived for several years (12). Similar to the previous two reported patients who lacked mutations of the mitochondrial genes ATP6 and ATP8 (12, 13), a clear reduction of the hydrolytic activity of mitochondrial ATPase (oligomycin sensitive) was found in investigated tissues.…”
The F o F 1 -ATPase, a multisubunit protein complex of the inner mitochondrial membrane, produces most of the ATP in mammalian cells. Mitochondrial diseases as a result of a dysfunction of ATPase can be caused by mutations in mitochondrial DNA-encoded ATPase subunit a or rarely by an ATPase defect of nuclear origin. Here we present a detailed functional and immunochemical analysis of a new case of selective and generalized ATPase deficiency found in an Austrian patient. The defect manifested with developmental delay, muscle hypotonia, failure to thrive, ptosis, and varying lactic acidemia (up to 12 mmol/L) beginning from the neonatal period. A low-degree dilated cardiomyopathy of the left ventricle developed between the age of 1 and 2 y. A Ͼ90% decrease in oligomycin-sensitive ATPase activity and an 86% decrease in the content of the ATPase complex was found in muscle mitochondria. It was associated with a significant decrease of ADP-stimulated respiration of succinate (1.5-fold) and respiratory control with ADP (1.7-fold) in permeabilized muscle fibers, and with a slight decrease of the respiratory chain complex I and compensatory increase in the content of complexes III and IV. The same ATPase deficiency without an increase in respiratory chain complexes was found in fibroblasts, suggesting a generalized defect with tissue-specific manifestation. Absence of any mutations in mitochondrial ATP6 and ATP8 genes indicates a nuclear origin of the defect. Mitochondrial disorders caused by impairment of mitochondrial oxidative phosphorylation (OXPHOS) affect predominantly tissues with high-energy demands: muscle, brain, and heart. Subunits of OXPHOS complexes are encoded in two separate genomes: nuclear and mitochondrial. A pathogenic mutation in both genomes can cause an OX-PHOS defect. Defects in complex V-mitochondrial F o F 1 -ATPase are less frequent than the defects of the respiratory chain complexes, but they are mostly very severe and can be caused by mitochondrial DNA (mtDNA) mutations or by mutations in nuclear genes.Mitochondrial ATPase is a multisubunit complex composed of 16 different subunits (1). Six of these compose the globular F 1 part, which is responsible for enzymatic catalysis of ATP synthesis or hydrolysis. Ten remaining subunits form the membrane-spanning F o part, which performs H ϩ translocation across the inner mitochondrial membrane. Four subunits of F o form stalks that connect F 1 and F o parts. Only two subunits from F o part are encoded by mitochondrial genome: subunits a and A6L (subunits 6 and 8) (2). All of the other 14 subunits of the ATPase are encoded by the nuclear genes.Specific defects in mitochondrial ATPase are caused mainly by mtDNA mutations that affect subunit a; no mutations in subunit A6L have been described so far. The most frequent mutation in subunit a is T8993G mutation (3-7) or T8993C mutation (8)
“…Lactic acidosis or other evidence of mitochondrial dysfunction occur in some patients with idiopathic 3MGC-aciduria (1, 2). Similarly, several patients with well-defined primary mitochondrial disorders, such as ATP-synthase deficiency and Pearson syndrome, have been found to excrete excessive amounts of 3MGC (5,6), suggesting that mitochondrial dysfunction may be primary in some patients with idiopathic 3MGC aciduria. In such patients, one mechanism for increased 3MGC-aciduria could be failure of mitochondrial uptake of peroxisomally or cytoplasmically synthesized 3MGC.…”
Section: Resultsmentioning
confidence: 99%
“…Except in several patients with mild neurologic abnormalities caused by a genetic deficiency of 3-methylglutaconyl-CoA hydratase (3,4), provocative testing including fasting, oral loading with i-leucine, and high protein diets have had little effect on the excretion of 3MGC, even in patients with 50-to 100-fold increased excretion of 3MGC. And whereas a few patients with excessive 3MGC aciduria have been found to have a primary defect of mitochondrial energy metabolism (5,6), most searches for a specific metabolic lesion in patients with 3MGC aciduria prove fruitless.…”
“…ATP6 and subunit 9 (ATP9) are known to be major components of the proton channel Qf the ATP synthase (31,32), and it has been postulated that the leucine at position 156 in ATP6 sits adjacent to a glutamate in ATP9, creating a protonation site essential for proton translocation. Substitution of a positively charged arginine for the leucine would then neuttalize the negative charge of the glutamate and block the channel (30 (34,37,38), low F1 ATPase activity was also found, indicating a defective nuclear-encoded subunit of the complex. The patients described by Schotland et al (38) and Holme et al (37) sit at the ends of the clinical spectrum of oxidative phosphorylation disease, perhaps representing a mild tissue-specific mutant versus a severe mutant with systemic expression such as 8993 T-3 G. The similarity ofthe clinical picture of the patient described by Clark et al (34) to that of nt 8993 NARP patients (5-8, 10) also suggests that defects in different subunits of the H+-ATP synthase complex can lead to similar clinical pictures.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.